Recruiting NCT07070726

UNTOLD Ovarian Cancer Unmet Needs Survey

— Observational Ovarian Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to: Registry conditions: Ovarian Cancer. Basic parameters: from 18 years · Female.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: United States
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

UNderstanding The Experience of Ovarian Cancer Life After Diagnosis (UNTOLD) Study

Overview

The goal of this study is to comprehensively measure ongoing concerns and unmet needs of individuals living with ovarian cancer. To accomplish this, the UNderstanding The experience of Ovarian cancer - Life after Diagnosis (UNTOLD) study will be conducted using a mixed-methods approach. Ovarian cancer survivors will be enrolled to participate in UNTOLD to complete a one-time survey regarding their experiences. Up to 40 survivors will be subsequently identified to complete a follow-up interview. To ensure these sample sizes, along with a representative sample, a combined recruitment strategy will be employed using the California Cancer Registry (population-based) and recruitment through ovarian cancer advocacy groups.

Primary outcome measures

Supportive Care Needs [Time frame: Day 1]

Secondary outcome measures (1)

Quality of Life - Average FACT general total score [Time frame: Day 1]

Eligibility criteria

Inclusion criteria

Ability to read and write in English
Diagnosed with ovarian cancer (ovarian, primary peritoneal, fallopian tube)

Exclusion criteria

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model: Other

Study locations

United States · 1 center

Masonic Cancer Center — Minneapolis

Identifiers

NCT: NCT07070726 · 2024LS181 · 1U48DP006876

Primary sources (government registries)

ClinicalTrials.gov (US NIH)

View this study on ClinicalTrials.gov ↗